Access

Letter

Nature 453, 529-533 (22 May 2008) | doi:10.1038/nature06933; Received 30 October 2007; Accepted 25 March 2008; Published online 7 May 2008

Open Innovation Challenges

naturejobs

  • Chair

    • McMaster University
    • Hamilton, Canada
  • PhD student position

    • Laval University Cancer Research Center
    • Quebec city, CANADA

Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation

Wei Guo1, Joseph L. Lasky2, Chun-Ju Chang1, Sherly Mosessian1, Xiaoman Lewis1, Yun Xiao5, Jennifer E. Yeh6, James Y. Chen1, M. Luisa Iruela-Arispe3, Marileila Varella-Garcia5 & Hong Wu1,4

  1. Department of Molecular and Medical Pharmacology,
  2. Department of Pediatric Hematology/Oncology,
  3. Department of Molecular, and,
  4. Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Cellular and Developmental Biology, University of California, Los Angeles, Los Angeles, California 90095, USA
  5. Department of Medicine, Medical Oncology Division, University of Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
  6. Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA

Correspondence to: Hong Wu1,4 Correspondence and requests for materials should be addressed to H.W. (Email: hwu@mednet.ucla.edu).

Top

Cancer stem cells, which share many common properties and regulatory machineries with normal stem cells, have recently been proposed to be responsible for tumorigenesis and to contribute to cancer resistance1. The main challenges in cancer biology are to identify cancer stem cells and to define the molecular events required for transforming normal cells to cancer stem cells. Here we show that Pten deletion in mouse haematopoietic stem cells leads to a myeloproliferative disorder, followed by acute T-lymphoblastic leukaemia (T-ALL). Self-renewable leukaemia stem cells (LSCs) are enriched in the c-KitmidCD3+Lin- compartment, where unphosphorylated beta-catenin is significantly increased. Conditional ablation of one allele of the beta-catenin gene substantially decreases the incidence and delays the occurrence of T-ALL caused by Pten loss, indicating that activation of the beta-catenin pathway may contribute to the formation or expansion of the LSC population. Moreover, a recurring chromosomal translocation, T(14;15), results in aberrant overexpression of the c-myc oncogene in c-KitmidCD3+Lin- LSCs and CD3+ leukaemic blasts, recapitulating a subset of human T-ALL. No alterations in Notch1 signalling are detected in this model, suggesting that Pten inactivation and c-myc overexpression may substitute functionally for Notch1 abnormalities2, 3, leading to T-ALL development. Our study indicates that multiple genetic or molecular alterations contribute cooperatively to LSC transformation.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Highlights

Clinical Pharmacology & Therapeutics News and Views